Kılıçkap, S. Et Al. 2018. The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey. European Society for Medical Onkology 2018 Congress , (Munich, Germany).

Kılıçkap, S., Ölmez, Ö. F., Çiçin, İ., Demirci, U., Alan, Ö., Çabuk, D., ... Şakalar, T.(2018). The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey . European Society for Medical Onkology 2018 Congress, Munich, Germany

Kılıçkap, Saadettin Et Al. "The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey," European Society for Medical Onkology 2018 Congress, Munich, Germany, 2018

Kılıçkap, Saadettin Et Al. "The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey." European Society for Medical Onkology 2018 Congress , Munich, Germany, 2018

Kılıçkap, S. Et Al. (2018) . "The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey." European Society for Medical Onkology 2018 Congress , Munich, Germany.

@conferencepaper{conferencepaper, author={Saadettin Kılıçkap Et Al. }, title={The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey}, congress name={European Society for Medical Onkology 2018 Congress}, city={Munich}, country={Germany}, year={2018}}